...
首页> 外文期刊>Medical science monitor : >Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.
【24h】

Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling.

机译:酪氨酸和酪胺可在体内和体外增加内源性神经节吗啡和多巴胺的水平:cyp2d6和酪氨酸羟化酶调节显示出多巴胺偶联。

获取原文

摘要

BACKGROUND: The ability of animals to make morphine has been in question for the last 30 years. Studies have demonstrated that animals do contain morphine precursors and metabolites, as well as the ability to use some morphine precursors to make morphine. MATERIAL/METHODS: The present study uses excised ganglia from the marine invertebrate Mytilus edulis as well as whole animals. Morphine and dopamine levels were determined by high performance liquid chromatography coupled to electrochemical detection and radioimmunoassay. Tissues and whole animals were also exposed to morphine precursors and exposed to the CYP2D6 inhibitor quinidine and the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (AMPT). Additionally, via RT-PCR, a cDNA fragment of the CYP2D6 enzyme in the ganglia of M. edulis was identified. RESULTS: Pedal ganglia incubated with either tyramine or tyrosine, or whole animals receiving injections, exhibited a statistically significant concentration- and time-dependent increase in their endogenous morphine and dopamine levels (2.51 +/- 0.76 ng/g for tyrosine and 2.39 +/- 0.64 ng/g for tyramine compared to approximately 1.0 ng/g morphine wet weight). Incubation with quinidine and/or AMPT diminished ganglionic morphine and dopamine synthesis at various steps in the synthesis process. We also demonstrated that CYP2D6 mediates the tyramine to dopamine step in this process, as did tyrosine hydroxylase in the step from tyrosine to L-DOPA. Furthermore, via RT-PCR, we identified a cDNA fragment of the CYP2D6 enzyme in the ganglia, which exhibits 94% sequence identity with its human counterpart. Evidence that tyrosine and tyramine were, in part, being converted to dopamine then morphine, and that this process can be inhibited by altering either or both CYP2D6 or tyrosine hydroxylase, is also provided. CONCLUSIONS: It appears that animals have the ability to make morphine. This process also appears to be dynamic in that the inhibition of one pathway allows the other to continue with morphine synthesis. Moreover, dopamine and morphine synthesis were coupled.
机译:背景:在过去的30年中,动物产生吗啡的能力一直受到质疑。研究表明,动物确实含有吗啡前体和代谢产物,以及使用某些吗啡前体制造吗啡的能力。材料/方法:本研究使用了从无脊椎动物无脊椎动物Mytilus edulis以及整个动物身上切除的神经节。通过高效液相色谱结合电化学检测和放射免疫测定法测定吗啡和多巴胺水平。组织和整个动物也暴露于吗啡前体,并暴露于CYP2D6抑制剂奎尼丁和酪氨酸羟化酶抑制剂α-甲基-对-酪氨酸(AMPT)。另外,通过RT-PCR,鉴定了蓝靛果神经节中CYP2D6酶的cDNA片段。结果:与酪胺或酪氨酸一起孵育的踏板神经节,或接受注射的整个动物,其内源性吗啡和多巴胺水平在浓度和时间上均具有统计学意义的升高(酪氨酸为2.51 +/- 0.76 ng / g,2.39 + / -酪胺为0.64 ng / g,而吗啡湿重约为1.0 ng / g。在合成过程的各个步骤中,与奎尼丁和/或AMPT一起孵育可减少神经节吗啡和多巴胺的合成。我们还证明了CYP2D6在此过程中介导了酪胺向多巴胺的转化,就像酪氨酸羟化酶在从酪氨酸到L-DOPA的转化中一样。此外,通过RT-PCR,我们在神经节中鉴定了CYP2D6酶的cDNA片段,该片段与人类对应物具有94%的序列同一性。还提供了酪氨酸和酪胺被部分转化为多巴胺然后为吗啡的证据,并且可以通过改变CYP2D6或酪氨酸羟化酶之一或两者来抑制该过程。结论:看来动物具有制造吗啡的能力。该过程似乎是动态的,因为一个途径的抑制使另一途径继续进行吗啡合成。此外,多巴胺和吗啡合成是耦合的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号